U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
195330195330Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast CancerCompletedNo Results AvailableBreast CancerBiological: trastuzumab|Drug: pegylated liposomal doxorubicin hydrochloridehttps://ClinicalTrials.gov/show/NCT00004925
195301195301Study of Brain Activity During Speech Production and Speech PerceptionCompletedNo Results AvailableDevelopmental Articulation Disorder|Stutteringhttps://ClinicalTrials.gov/show/NCT00004991
195302195302Once-A-Month Steroid Treatment for Patients With Focal Segmental GlomerulosclerosisCompletedNo Results AvailableGlomerulonephritis|Nephrotic SyndromeDrug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT00004990
195303195303Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium BacteriaCompletedNo Results AvailableCancer|Neoplasm|Neoplasm MetastasisDrug: VNP20009https://ClinicalTrials.gov/show/NCT00004988
195304195304Treatment of Advanced AIDS Patients With Dextrin SulfateActive, not recruitingNo Results AvailableHIV InfectionsDrug: Dextrin 2-sulfatehttps://ClinicalTrials.gov/show/NCT00004987
195305195305Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS PatientsTerminatedNo Results AvailableCryptosporidiosis|HIV InfectionsDrug: Nitazoxanidehttps://ClinicalTrials.gov/show/NCT00004986
195306195306Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination TherapyCompletedNo Results AvailableHIV InfectionsDrug: Capravirine|Drug: Nelfinavir mesylatehttps://ClinicalTrials.gov/show/NCT00004985
195307195307The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)CompletedNo Results AvailableDiabetes Mellitus, Type 1Drug: Crystallized human recombinant insulinhttps://ClinicalTrials.gov/show/NCT00004984
195308195308Education and Group Support for Diabetic HispanicsCompletedNo Results AvailableDiabetes Mellitus, Non-Insulin-DependentBehavioral: diabetes self-management educationhttps://ClinicalTrials.gov/show/NCT00004983
195309195309Combination Iron Chelation TherapyCompletedNo Results AvailableIron Overload|ThalassemiaDrug: Combination Iron Chelation Therapyhttps://ClinicalTrials.gov/show/NCT00004982
195310195310Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)Active, not recruitingNo Results AvailableHIV InfectionsDrug: Abacavir sulfate, Lamivudine and Zidovudine|Drug: Lamivudine/Zidovudine|Drug: Abacavir sulfatehttps://ClinicalTrials.gov/show/NCT00004981
195311195311Repetitive Transcranial Magnetic Stimulation for "Voices"CompletedHas ResultsSchizophreniaDevice: repetitive transcranial magnetic stimulation (rTMS)|Device: sham stimulationhttps://ClinicalTrials.gov/show/NCT00004980
195312195312Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: paclitaxel|Drug: topotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00004979
195313195313An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral TherapyCompletedHas ResultsHIV InfectionsDrug: Recombinant interleukin-2 (rIL-2)https://ClinicalTrials.gov/show/NCT00004978
195314195314Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's DiseaseCompletedNo Results AvailableCrohn's DiseaseDrug: monoclonal antibody cA2https://ClinicalTrials.gov/show/NCT00004941
195315195315Phase III Study of L-Cysteine in Patients With Erythropoietic ProtoporphyriaCompletedNo Results AvailableErythropoietic ProtoporphyriaDrug: cysteine hydrochloridehttps://ClinicalTrials.gov/show/NCT00004940
195316195316Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating PolyneuropathyCompletedNo Results AvailablePolyradiculoneuropathy, Chronic Inflammatory DemyelinatingDrug: ,4-diaminopyridinehttps://ClinicalTrials.gov/show/NCT00004939
195317195317Phase II Study of Fluconazole for Lymphocutaneous and Visceral SporotrichosisCompletedNo Results AvailableSporotrichosisDrug: fluconazolehttps://ClinicalTrials.gov/show/NCT00004938
195318195318Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: acridine carboxamidehttps://ClinicalTrials.gov/show/NCT00004937
195319195319MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating PatientsCompletedNo Results AvailableCervical CancerDrug: iodinated contrast dye|Procedure: computed tomography|Procedure: magnetic resonance imaging|Radiation: gadopentetate dimegluminehttps://ClinicalTrials.gov/show/NCT00004936
195320195320Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2Active, not recruitingNo Results AvailableBreast CancerDrug: Herceptinâ„¢ (Her)|Drug: Herceptinâ„¢ (Her) + chemohttps://ClinicalTrials.gov/show/NCT00004935
195321195321Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal CancerCompletedNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity CancerDrug: carboplatin|Drug: epirubicin hydrochloride|Drug: paclitaxel|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00004934
195322195322Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon AlfaTerminatedNo Results AvailableLeukemiaDrug: hydroxyurea|Drug: Homoharringtoninehttps://ClinicalTrials.gov/show/NCT00004933
195323195323STI571 in Treating Patients With Recurrent LeukemiaCompletedNo Results AvailableLeukemiaDrug: imatinib mesylatehttps://ClinicalTrials.gov/show/NCT00004932
195324195324Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon CancerCompletedNo Results AvailableStage II Colon Cancer|Stage III Colon CancerDrug: leucovorin calcium|Drug: fluorouracil|Drug: oxaliplatin|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00004931
195325195325Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung MetastasesCompletedNo Results AvailableLung Cancer|Metastatic CancerDrug: doxorubicin hydrochloridehttps://ClinicalTrials.gov/show/NCT00004930
195326195326Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate CancerCompletedNo Results AvailableProstate CancerBiological: MUC-2-KLH vaccine|Biological: QS21https://ClinicalTrials.gov/show/NCT00004929
195327195327Calcitriol and Zoledronate in Treating Patients With Progressive Prostate CancerCompletedNo Results AvailableProstate CancerDietary Supplement: calcitriol|Drug: zoledronic acidhttps://ClinicalTrials.gov/show/NCT00004928
195328195328BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: ixabepilonehttps://ClinicalTrials.gov/show/NCT00004927
195329195329ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous TherapyCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDietary Supplement: vitamin D3 analogue ILX23-7553https://ClinicalTrials.gov/show/NCT00004926

* Görseller ve İçerik tekif hakkına sahip olabilir